|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.00 GBX | -1.94% |
|
-2.29% | -1.58% |
| Dec. 09 | Deutsche Bank Research raises Relx to 'buy' | AN |
| Nov. 17 | RS Group raised to 'buy' from 'neutral' | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 3.71 | 2.47 | 3.07 | 4.24 | 6.91 | ||||
Return on Total Capital | 4.39 | 2.87 | 3.58 | 4.95 | 8.16 | ||||
Return On Equity % | -24.02 | -104.73 | -157.75 | -2.07K | -2.08K | ||||
Return on Common Equity | -23.97 | -104.73 | -194.55 | 333.67 | -105.35 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 35.72 | 34.25 | 34.74 | 37.53 | 48.37 | ||||
SG&A Margin | 13.02 | 11.45 | 13.29 | 12.5 | 12.4 | ||||
EBITDA Margin % | 50.97 | 46.83 | 45.02 | 45.62 | 48.32 | ||||
EBITA Margin % | 19.95 | 15.16 | 19.23 | 23.3 | 34.99 | ||||
EBIT Margin % | 18.99 | 14.79 | 17.83 | 20.4 | 31.58 | ||||
Income From Continuing Operations Margin % | -8.86 | -34.78 | -30.57 | -15.51 | 3.41 | ||||
Net Income Margin % | -8.86 | -34.78 | -30.59 | -13.88 | 4.23 | ||||
Net Avail. For Common Margin % | -8.86 | -34.78 | -30.59 | -13.88 | 4.23 | ||||
Normalized Net Income Margin | 2.88 | -15.59 | -15.94 | -8.01 | 3.99 | ||||
Levered Free Cash Flow Margin | -8.28 | -6.31 | -27.64 | 0.92 | 7.62 | ||||
Unlevered Free Cash Flow Margin | 6.48 | 11.71 | -11.93 | 16.11 | 22.77 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.31 | 0.27 | 0.28 | 0.33 | 0.35 | ||||
Fixed Assets Turnover | 0.57 | 0.57 | 0.56 | 0.63 | 0.66 | ||||
Receivables Turnover (Average Receivables) | 4.04 | 5.64 | 3.86 | 3.47 | 3.15 | ||||
Inventory Turnover (Average Inventory) | 29.08 | 30.29 | 29.16 | 33 | 36.03 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 3.06 | 2.7 | 1.43 | 1.22 | 1.34 | ||||
Quick Ratio | 2.82 | 2.51 | 1.16 | 1.08 | 1.22 | ||||
Operating Cash Flow to Current Liabilities | 0.3 | 0.13 | 0.17 | 0.39 | 0.52 | ||||
Days Sales Outstanding (Average Receivables) | 90.57 | 64.73 | 94.59 | 105.1 | 116.02 | ||||
Days Outstanding Inventory (Average Inventory) | 12.58 | 12.05 | 12.52 | 11.06 | 10.16 | ||||
Average Days Payable Outstanding | 21.07 | 16.11 | 22.44 | 25.76 | 31.18 | ||||
Cash Conversion Cycle (Average Days) | 82.09 | 60.68 | 84.66 | 90.4 | 95 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 860.4 | 879.4 | 3.65K | -4.95K | 5.42K | ||||
Total Debt / Total Capital | 89.59 | 89.79 | 97.33 | 102.06 | 98.19 | ||||
LT Debt/Equity | 840.37 | 858.1 | 3.54K | -4.76K | 5.21K | ||||
Long-Term Debt / Total Capital | 87.5 | 87.61 | 94.41 | 98.14 | 94.5 | ||||
Total Liabilities / Total Assets | 90.89 | 91.31 | 97.7 | 101.75 | 98.46 | ||||
EBIT / Interest Expense | 0.8 | 0.51 | 0.71 | 0.84 | 1.3 | ||||
EBITDA / Interest Expense | 2.3 | 1.74 | 1.94 | 2.06 | 2.13 | ||||
(EBITDA - Capex) / Interest Expense | 1.04 | 0.44 | 0.21 | 0.96 | 1.38 | ||||
Total Debt / EBITDA | 4.98 | 6.55 | 6.57 | 5.28 | 4.76 | ||||
Net Debt / EBITDA | 3.08 | 4.2 | 6.13 | 4.98 | 4.37 | ||||
Total Debt / (EBITDA - Capex) | 11.03 | 25.87 | 61.35 | 11.27 | 7.36 | ||||
Net Debt / (EBITDA - Capex) | 6.81 | 16.61 | 57.27 | 10.64 | 6.75 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 6.76 | 8.48 | 24.85 | 28.59 | 9.85 | ||||
Gross Profit, 1 Yr. Growth % | 17.47 | 3.99 | 26.66 | 38.91 | 41.57 | ||||
EBITDA, 1 Yr. Growth % | 9.04 | 4.01 | 13.34 | 30.31 | 16.36 | ||||
EBITA, 1 Yr. Growth % | 29.06 | -7.72 | 33.91 | 55.84 | 59.99 | ||||
EBIT, 1 Yr. Growth % | 35.52 | -4.87 | 26.9 | 47.1 | 70.02 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | -73.13 | 325.61 | 9.73 | -34.77 | -124.15 | ||||
Net Income, 1 Yr. Growth % | -73.01 | 325.61 | 9.8 | -41.63 | -133.47 | ||||
Normalized Net Income, 1 Yr. Growth % | -268.43 | -1.19K | 43.53 | -35.38 | -154.67 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | -73.33 | 281.24 | 7.41 | -38.95 | -130 | ||||
Accounts Receivable, 1 Yr. Growth % | -33.01 | -6.2 | 33.79 | 49.67 | 1.73 | ||||
Inventory, 1 Yr. Growth % | -3.23 | 16.67 | 39.05 | -13.01 | -21.26 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.89 | 24.99 | 30.15 | 3.34 | 4.74 | ||||
Total Assets, 1 Yr. Growth % | 17.21 | 35.2 | 10.96 | 2.74 | 5.94 | ||||
Tangible Book Value, 1 Yr. Growth % | -27.39 | -155.37 | 807.26 | 8.43 | -14.32 | ||||
Common Equity, 1 Yr. Growth % | -25.92 | 28.93 | -95.06 | -922.89 | -106.88 | ||||
Cash From Operations, 1 Yr. Growth % | 58.24 | -39.66 | 42.34 | 188.06 | 34.71 | ||||
Capital Expenditures, 1 Yr. Growth % | 29.62 | 36.55 | 45.04 | -21.48 | -24.75 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -150.6 | -28.8 | 474.2 | -104.69 | 809.6 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -78.68 | 146.66 | -224 | -317.08 | 55.26 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 7.84 | 7.61 | 16.38 | 26.71 | 18.85 | ||||
Gross Profit, 2 Yr. CAGR % | 21.49 | 10.53 | 14.77 | 32.64 | 40.24 | ||||
EBITDA, 2 Yr. CAGR % | 13.78 | 4.25 | 11.73 | 21.53 | 23.14 | ||||
EBITA, 2 Yr. CAGR % | 45.53 | 3.15 | 20.86 | 44.46 | 60.33 | ||||
EBIT, 2 Yr. CAGR % | 52.04 | 7 | 19.69 | 36.63 | 58.15 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -45.58 | 6.93 | 116.11 | -15.4 | -60.31 | ||||
Net Income, 2 Yr. CAGR % | -45.58 | 7.17 | 116.17 | -19.95 | -55.8 | ||||
Normalized Net Income, 2 Yr. CAGR % | -53.62 | 214.27 | 272.55 | -3.69 | -40.57 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -46.55 | 0.83 | 102.36 | -19.02 | -57.2 | ||||
Accounts Receivable, 2 Yr. CAGR % | 4.34 | -20.73 | 42.24 | 41.51 | 23.39 | ||||
Inventory, 2 Yr. CAGR % | -6.52 | 6.26 | 27.37 | 9.98 | -17.24 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -5.03 | 9.03 | 26.78 | 16.13 | 4.04 | ||||
Total Assets, 2 Yr. CAGR % | 18.54 | 25.88 | 22.44 | 6.64 | 4.33 | ||||
Tangible Book Value, 2 Yr. CAGR % | -1.01 | -36.59 | 131.75 | 211.38 | -3.61 | ||||
Common Equity, 2 Yr. CAGR % | 3.47 | -2.27 | -74.76 | -36.24 | -24.75 | ||||
Cash From Operations, 2 Yr. CAGR % | -1.24 | -2.29 | -7.33 | 102.49 | 96.99 | ||||
Capital Expenditures, 2 Yr. CAGR % | 9.46 | 33.04 | 40.73 | 6.72 | -23.13 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 42.37 | -35.34 | 97.32 | -50.41 | -34.69 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -39.19 | -35.35 | 77.12 | 46.72 | 83.58 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 6.27 | 8.05 | 13.08 | 20.31 | 20.82 | ||||
Gross Profit, 3 Yr. CAGR % | 28.75 | 15.35 | 15.66 | 22.31 | 35.56 | ||||
EBITDA, 3 Yr. CAGR % | 17.56 | 8.86 | 9.26 | 17.61 | 19.78 | ||||
EBITA, 3 Yr. CAGR % | 80.99 | 20.42 | 18.98 | 31.55 | 50.99 | ||||
EBIT, 3 Yr. CAGR % | 166.05 | 25 | 19.91 | 28.21 | 46.96 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -30.1 | 8.03 | 7.86 | 44.96 | -44.3 | ||||
Net Income, 3 Yr. CAGR % | -26.6 | 8.03 | 8.04 | 39.72 | -40.14 | ||||
Normalized Net Income, 3 Yr. CAGR % | -32.11 | 8.04 | 132.74 | 107.77 | -20.26 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -26.83 | 2.89 | 2.98 | 35.72 | -41.84 | ||||
Accounts Receivable, 3 Yr. CAGR % | 1.89 | 0.7 | 10.67 | 44.67 | 26.76 | ||||
Inventory, 3 Yr. CAGR % | -1.92 | 0.64 | 16.22 | 12.16 | -1.61 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -4.6 | 4.08 | 15.2 | 18.53 | 12.2 | ||||
Total Assets, 3 Yr. CAGR % | 8.7 | 23.85 | 20.67 | 15.39 | 6.4 | ||||
Tangible Book Value, 3 Yr. CAGR % | -22.9 | -18.44 | 57.4 | 79.04 | 102.53 | ||||
Common Equity, 3 Yr. CAGR % | -19.69 | 11.35 | -63.86 | -19.37 | -69.64 | ||||
Cash From Operations, 3 Yr. CAGR % | 1.1 | -16.2 | 10.77 | 35.25 | 76.77 | ||||
Capital Expenditures, 3 Yr. CAGR % | -9.54 | 17.83 | 36.93 | 15.86 | -5.01 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | -34.82 | 18.75 | 31.73 | -44.96 | 30.79 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -28.89 | -10.16 | -18.99 | 75.94 | 49.51 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 9.71 | 10.2 | 15.16 | 15.35 | ||||
Gross Profit, 5 Yr. CAGR % | - | 26.95 | 22.96 | 21.98 | 24.93 | ||||
EBITDA, 5 Yr. CAGR % | - | 15.7 | 14.22 | 15.07 | 14.61 | ||||
EBITA, 5 Yr. CAGR % | - | 70.79 | 50.56 | 33.92 | 34.06 | ||||
EBIT, 5 Yr. CAGR % | - | 21.22 | 88.75 | 34.04 | 33.95 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 6.11 | 9.79 | -2.03 | -27.69 | ||||
Net Income, 5 Yr. CAGR % | - | 9.83 | 13.06 | -4.18 | -24.44 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 8.15 | 18.55 | 0.79 | 34.81 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 7.24 | 9.92 | -6.51 | -27.52 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | -5.08 | 16.44 | 26.94 | 15.59 | ||||
Inventory, 5 Yr. CAGR % | - | -11.65 | 8.89 | 4.28 | 1.46 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 2.76 | 6.89 | 8.48 | 10.66 | ||||
Total Assets, 5 Yr. CAGR % | - | 11.84 | 14 | 16.64 | 13.79 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | -30.75 | 19.74 | 41.26 | 28.99 | ||||
Common Equity, 5 Yr. CAGR % | - | -16.26 | -49.46 | -10.91 | -51.54 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 7.25 | -2.36 | 19.27 | 39.45 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | -9.25 | 7.95 | 13.25 | 8.69 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 4.58 | -17.07 | -2.29 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | -2.15 | 9.87 | 7.46 |
- Stock Market
- Equities
- HTWS Stock
- Financials Helios Towers plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















